David Dalvey Biography and Net Worth

Director of Celcuity

Dave has served as a member of Celcuity’s board of directors since February 2014. Dave has more than 30 years of experience in the fields of corporate finance and venture capital, working primarily with growth-oriented technology and life-science businesses. He has over 10 years of corporate finance advisory experience with two national investment banks, completing over 150 individual transactions. He has been the General Partner of Brightstone Venture Capital, a venture capital management company, since September 2000. Brightstone is a 25-year-old venture capital management company that has raised and managed 10 venture partnerships. Dave received a BS in Business/Management Economics from University of Minnesota and an MBA—Business & Finance, from the University of Minnesota Carlson School of Management.

What is David Dalvey's net worth?: The estimated net worth of David Dalvey is at least $13.23 million as of July 28th, 2025. Mr. Dalvey owns 125,000 shares of Celcuity stock worth more than $13,233,750 as of December 4th. This net worth evaluation does not reflect any other assets that Mr. Dalvey may own. Learn More about David Dalvey's net worth.
How do I contact David Dalvey?: The corporate mailing address for Mr. Dalvey and other Celcuity executives is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. Celcuity can also be reached via phone at (763) 392-0767. Learn More on David Dalvey's contact information.
Has David Dalvey been buying or selling shares of Celcuity?: David Dalvey has not been actively trading shares of Celcuity within the last three months. Most recently, David Dalvey sold 9,325 shares of the business's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $45.12, for a transaction totalling $420,744.00. Learn More on David Dalvey's trading history.
Who are Celcuity's active insiders?: Celcuity's insider roster includes Richard Buller (Director), and David Dalvey (Director). Learn More on Celcuity's active insiders.
Are insiders buying or selling shares of Celcuity?: In the last year, insiders at the sold shares 3 times. They sold a total of 113,225 shares worth more than $5,195,991.00. The most recent insider tranaction occured on November, 20th when Director Richard E Buller sold 3,900 shares worth more than $377,247.00. Insiders at Celcuity own 15.8% of the company. Learn More about insider trades at Celcuity.
Information on this page was last updated on 11/20/2025.

David Dalvey Insider Trading History at Celcuity

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/28/2025	Sell	9,325	$45.12	$420,744.00
7/28/2025	Sell	100,000	$43.98	$4,398,000.00	125,000
12/12/2023	Sell	2,060	$14.61	$30,096.60	237,940
12/8/2023	Sell	5,000	$15.00	$75,000.00	240,000

David Dalvey Buying and Selling Activity at Celcuity

Celcuity Company Overview

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $105.87

$98.74

$107.35

50 Day Range

MA: $73.63

$45.22

$105.87

2 Week Range

Now: $105.87

$7.57

$107.35

Volume

783,471 shs

Average Volume

871,750 shs

Market Capitalization

$4.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21